Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study

OBJECTIVE: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been recently reported with favorable oncological outcomes as treatment of advanced epithelial ovarian cancer (EOC). The aim of this study was to demonstrate the feasibility of CRS+HIPEC with cisplatin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Gynecol Oncol
Main Authors: Coccolini, Federico, Campanati, Luca, Catena, Fausto, Ceni, Valentina, Ceresoli, Marco, Jimenez Cruz, Jorge, Lotti, Marco, Magnone, Stefano, Napoli, Josephine, Rossetti, Diego, De Iaco, Pierandrea, Frigerio, Luigi, Pinna, Antonio, Runnebaum, Ingo, Ansaloni, Luca
Formato: Artigo
Idioma:Inglês
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2015
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4302286/
https://ncbi.nlm.nih.gov/pubmed/25376916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2015.26.1.54
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares